Innovotech (CVE:IOT) Shares Down 12.5% – Should You Sell?

Innovotech Inc. (CVE:IOT)’s share price dropped 12.5% during trading on Wednesday . The stock traded as low as C$0.07 and last traded at C$0.07. Approximately 206,000 shares changed hands during mid-day trading, an increase of 331% from the average session volume of 47,756 shares. The stock had previously closed at C$0.08.

Innovotech Stock Performance

The firm’s fifty day moving average is C$0.09 and its 200 day moving average is C$0.15. The company has a debt-to-equity ratio of 12.55, a current ratio of 2.63 and a quick ratio of 5.81. The firm has a market capitalization of C$4.08 million, a price-to-earnings ratio of -11.02 and a beta of 2.59.

About Innovotech

Innovotech Inc provides assay kits used in growing microbial biofilms for research purposes in Canada, the United States, and internationally. The company offers InnovoSIL, a silver periodate antimicrobial compounds for medical applications; MBEC Assay kit, a petri dish for biofilms, which are used for research and medical device testing of microbial biofilms; and AgreGuard, an antimicrobial for crop protection. It also provides antimicrobial contract research and antimicrobial testing; antimicrobial and anti-biofilm agents; antimicrobial and anti-biofilm materials; BEST assay testing; implanted medical devices; bacteriophage testing; and analytical services.